HIGHLIGHTS
- who: Adenocarcinoma et al. from the Biobank of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China have published the Article: Establishment and Application of a Prognostic Risk Score Model Based on Characteristics of Different Immunophenotypes for Lung Adenocarcinoma, in the Journal: (JOURNAL)
- what: With the application of immune checkpoint inhibitors (ICIs) attracting widespread attention, the indispensable role of TIICs in immunotherapy has also become a research focus.
- how: The authors conducted immunotyping of patients based on TIICs and constructed a prognostic risk model based on differentially expressed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.